Roadrunner
SILVER
It just seems an even sillier argument and unwarranted dichotomy, given that the same cellular processes that are being stimulated in both cases by the same protein BUT one enters the blood stream directly while natural infection does not.
A decline in circulating anti-spike antibodies over time is to be expected, unless the individuals are getting exposed repeatedly to SARS-CoV2 or boosters.
Someone with good immunity should be able to rapidly fill an order for new little green anti-spike army men because you've got the mold in stock (innate immunity), rather than needing to put in a special order and potentially deal with supply line slowdowns, all while trying to prevent the virus from gaining a strong foothold. The data here show the numbers of circulating anti-spike army men ready to do battle in different people. Lots of variability, no surprise. The immune cells remember how to make more quickly if needed, using the molds they have in stock. A question is how quickly can an individual ramp up their production relative to an invading virus. .. and whether the green anti-spike army men should be shaped a bit differently to best attack virus spike 2.0.